Business Results for the Fiscal Year
Ended March 31, 2019

from the beginning

Business Results Fiscal Year Ended March 31, 2019

• Change in the Information Disclosed in Presentation Materials

• Index

1. Financial Highlights for the Fiscal Year Ended March 31, 2019

• Financial Highlights

• Breakdown of Net Sales (by Geographic Region)

• Sales by Business and Product Type

• Breakdown of Operating Profit

• Breakdown of Assets and Liabilities/Equity

• Consolidated Cash Flows

• Topics

• Information by Destination (Americas)

• Information by Destination (EMEA)

• Information by Destination (China)

• Information by Destination (AP)

• Information by Destination (Japan)

• Status of Earnings at Consolidated Subsidiaries

• Dividend Forecast

• (Reference) Net Sales and Operating Profit by Geographic Region

2. Review of Previous Mid-Term Management Plan (Announced in May 2017)

• Review of Previous Mid-Term Management Plan (1)

• Review of Previous Mid-Term Management Plan (2)

3. Mid-Term Management Plan (Fiscal Years Ending March 31, 2020 to 2022)

• Operating Environment for the Mid-Term Management Plan

• Overview of the Mid-Term Management Plan

• Reinforce Strong Growth in the IVD Business (1)

• Reinforce Strong Growth in the IVD Business (2)

• Accelerate Commercialization of the Life Science Business

• Reinforce the Reagent Development and Manufacturing Functions, Which Support Business Growth

• Enhance Structures that Support the Business (Quality Assurance and Regulatory Affairs)

• Shore up the Management Base (Digitalization and Human Resource Management)

• Financial Policy (Three Years)

• Initiatives Targeting CSR Issues to Support Sustainable Growth

4. Consolidated Earnings Forecast for the Fiscal Year Ending March 31, 2020

• Consolidated Earnings Forecast

• Dividend Increases for the 18th Consecutive Year (Forecast for the Fiscal Year Ending March 31, 2020)

(Appendix) Financial Highlights for the Fiscal Year Ended March 31, 2019

• (Reference) Year-on-Year Growth, Excluding Extraordinary Factors

(Appendix) Mid-Term Management Targets

• Sales by Business

• Net Sales by Destination

• Sales and Operating Profit by Destination

@